Roche Partners with Rona for $1B RNAi Obesity Drug Targeting Visceral Fat | Retatrutide News

Roche has formed a $1 billion partnership with Rona Therapeutics to develop an RNAi drug targeting visceral fat. This move highlights the pharmaceutical...
Market News · October 14, 2026